📰 Pharma Intermediates News
Pharma Intermediates News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharma Intermediates. Real-time updates on events, politics, business and more.
November 28, 2023
The brokerage has a ‘buy’ recommendation on the stock with a target price of ₹528, indicating an upside of 10 percent from its current market price of ₹480.30.
October 26, 2023
Paragon Fine IPO: The initial public offering allotment will take place on November 1 and the shares are likely to be listed on the NSE SME on November 7
July 24, 2023
Aarti Drugs share price: On technical setup, the stock was last seen trading higher than the 5-day, 20-, 50-, 100- and 200-day moving averages. The counter's 14-day relative strength index (RSI) came at 83.71. A level below 30 is defined as oversold while a value above 70 is considered overbought. The company's stock has a price-to-earnings (P/E) ratio of 28.48 against a price-to-book (P/B) value of 4.24.
May 19, 2023
Eiko Lifesciences is currently trading at upper circuit limit of Rs. 74.60, up by 3.55 points or 5.00% from its previous closing of Rs. 71.05 on the BSE. The scrip opened at Rs. 73.98 and has touched a high and low of Rs. 74.60 and Rs. 73.00 respectively. So far 58227 shares were traded on
May 18, 2023
Gandhinagar, May 17 engaged in the manufacturing of Pharma Intermediates and APIs, Iodine derivatives has reported net profit of Rs. 9.49 crore for FY23, with Y-o-Y growth of 55.4% as compared to the net profit of Rs. 6.10 crore in FY22. Revenue from Operations grew 15.24% to Rs. 114.22 crore in FY23 as against revenue of Rs. 99.12 crore reported in FY22. Profit Before Tax during FY23 grew 50% to Rs. 12.95 crore as against Profit before Tax of Rs. 8.63 crore in FY22. EPS for FY23 is Rs. 18.67 p...
March 27, 2023
(This story has not been edited by THE WEEK and is auto-generated from a PTI
March 27, 2023
New Delhi [India], March 27 (ANI/PNN): Infinium Pharmachem Limited, engaged in the manufacturing and supplying of Iodine Derivatives, Pharma Intermediates and Active Pharmaceutical Ingredients (APIs), brings its IPO for Rs. 2525.72 Lakhs on the March 31, 2023.
August 27, 2021
Ami Organics IPO Price: Ami Organics is planning to raise Rs 569.64 crore from the IPO and has priced its shares in the band of Rs 603-610 per equity share.
March 8, 2021
Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs has received an approval accorded under Production Linked Incentive (PLI) scheme for pharmaceutical sector. Government of Indias Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in f...